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Rationale and Objectives: Dedicated breast computed tomography (DBCT) is an emerging and promising modality for breast lesions. 
The objective of this study was to evaluate the potential use of applying the BI-RADS Mammography Atlas 5th Edition for reporting 
and assessing breast lesions on DBCT. Currently, no atlas exists for DBCT.
Materials and Methods: Four radiologists trained in breast imaging were recruited in this institutional review board-approved, Health 
Insurance Portability and Accountability Act-compliant study. The enrolled radiologists, who were blinded to mammographic and his-
topathologic findings, individually reviewed 30 randomized DBCT cases that contained marked lesions. Thirty-four lesions were included 
in this study: 24 (70.6%) masses, 7 (20.6%) calcifications, and 3 (8.8%) architectural distortions. Eight (23.5%) lesions were malignant 
and 26 (76.5%) were benign. The reader was asked to specify according to the BI-RADS Mammography Atlas for each marked DBCT 
lesion: primary findings, features, breast density, and final assessment. We calculated readers’ diagnostic performances for differenti-
ating between benign and malignant lesions and interobserver variability for reporting and assessing lesions using a generalized estimating 
equation and the Fleiss kappa (κ) statistic.
Results: The estimated overall sensitivity of the readers was 0.969, and the specificity was 0.529. There were no significant differ-
ences in the sensitivity and the specificity between lesion types. For reporting the presence of a primary finding, the overall substantial 
agreement (κ = 0.70) was seen. In assigning the breast density and the final assessment, the overall agreement was moderate (κ = 0.53) 
and fair (κ = 0.30).
Conclusion: The use of the BI-RADS Mammography Atlas 5th Edition for DBCT showed high performance and good agreement among 
readers.
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INTRODUCTION
B reast Imaging Reporting and Data System (BI-RADS),established by the American College of Radiology, wasbegun in the late 1980s to address a lack of standard-
ization and uniformity in mammography practice and reporting
(1), and the BI-RADS lexicon has provided a valuable and
reliable guide for reporting breast lesions on mammography,
ultrasound, and magnetic resonance imaging (MRI), and has
been familiar to most radiologists specializing in breast imaging.
The descriptors in the BI-RADS lexicon have been selected on
the basis of their ability to discriminate between benignity and
malignancy as clear and standardized terms (2,3). BI-RADS has
also recommended that a final impression be summarized by choos-
ing only one among several standardized final assessment categories
at the end of a report, each of which included a matched, stan-
dardized management recommendation (4,5). The BI-RADS
atlas is intended to be a “living” document that changes as
new data are acquired and more sophisticated patterns of breast
care emerge (4). With continued evolvement of lesion char-
acterization and assessment for malignancy, the BI-RADS
Mammography Atlas is now in its fifth edition (6).
In addition to the updates in mammography, the fifth edition
contains standardized breast lesion lexicons and assessment lan-
guage for breast ultrasound and MRI. With advancements in
breast imaging technologies, such as dedicated computed to-
mography of the breast, the BI-RADS Mammography Atlas
can serve as the standard terminology upon which lexicons
in other areas of radiology and research can be modeled.
Mammography is the current gold standard for detecting breast
cancer in asymptomatic women and has been proven to decrease
mortality (7–9). However, this technology does have some limi-
tations because of the superimposition of anatomic structures.
In women with dense breasts, mammography has not been
proven as sensitive as in the population of women with nondense
breasts (10,11). In reaction to this problem, dedicated breast
computed tomography (DBCT), which provides three-
dimensional data that can be reconstructed into multiple imaging
planes, similar to breast MRI, has emerged as a new imaging
modality in some researchers (12–31). DBCT is performed
without breast compression and is not as limited as full-field
digital mammography or digital breast tomosynthesis by breast
density or breast implants (14,15,17). The radiation dose level
is similar to the dose of a conventional two-view digital mam-
mogram (23,24,26,28). Since the initial clinical experience of
DBCT was begun by Lindfors in 2008 (23), DBCT has showed
promising results for the diagnostic evaluation of breast lesions,
particularly for breast masses (12,20,25–29,31). Published ar-
ticles have shown that DBCT has shown a significant
improvement in the characterization or differentiation of breast
lesions using BI-RADS descriptor and category terminology
compared to digital mammography (20,31). However, to our
knowledge, there is no published study about the reproduc-
ibility of readers for reporting and assessing breast lesions on
DBCT with the use of BI-RADS. Determining the repro-
ducibility of BI-RADS is important because it can offer
standardized guidance in reporting and assessing breast lesions
with DBCT. Currently, no atlas exists for DBCT.
The purpose of the present study was to evaluate the di-
agnostic performance and the variability of multireaders for
the use of the BI-RADS Mammography Atlas 5th Edition
in reporting and assessing breast lesions on DBCT.
MATERIALS AND METHODS
Institutional review board approval was obtained for this ra-
diologist reader study. Informed verbal and written consent
was obtained from all of the readers involved in the present
study. The deidentified DBCT cases that were used in the
current study were from a DBCT image database of collect-
ed cases from two other institutional review board-approved,
Health Insurance Portability and Accountability Act-compliant
DBCT clinical trials. A total of 34 lesions in 30 subjects were
identified in the database and are included in our study. All
the lesions in the database had been assessed as BI-RADS 4
or 5 lesions with standard of care imaging, which consisted
of full-field digital mammography and their pathologic di-
agnoses based on image-guided percutaneous core needle biopsy
or surgical excision. All lesions were mammographically evident
on standard of care diagnostic evaluation. Pathologic results
for all lesions were evaluated with image-guided percutane-
ous core biopsy. In cases referred for excisional biopsy after
needle core biopsy because of the finding of atypia, malig-
nancy, or radiology-pathology discordance, final surgical
pathologic analysis was used for correlation with imaging find-
ings. At our institution, our protocol for breast lesions that
result in a diagnosis of atypia on needle core biopsy was to
perform surgical excision to exclude histologic underestimation.
Before the reader study, each lesion for each case was elec-
tronically marked and numbered on the images by the principle
investigator, who was familiar with the clinical, mammo-
graphic, and pathologic information of each case in the study.
Readers
Eligible radiologists were identified by research staff review
of their credentials from academic practice centers. A total
of four fellowship trained breast imaging radiologists were re-
cruited and enrolled in the present study. The readers had
1–13 years (mean of 7 years) of clinical experience and use
of the BI-RADS Mammography Atlas. According to self-
reports of the radiologists, they interpreted at least 140
mammography examinations (80–180) per week on average.
The readers had no experience of DBCT imaging as part of
their daily practice. To minimize reader bias, these breast
imaging radiologists possessed no conflicts of interest in the
research study or with the use of the device.
Data Description
Table 1 shows the cross-tabulation for the mammographic lesion
types and pathology of the 34 lesions. The 34 lesions
comprised of 24 (71%) masses, 7 (21%) calcifications, and 3
(9%) architectural distortions. Pathologic diagnosis was avail-
able for all lesions. Eight (24%) lesions were malignant and
26 (76%) were benign. Four subjects had bilateral lesions.
Twelve of the 34 lesions (35.3%) were associated with symp-
toms of palpable mass (n = 10) and focal pain (n = 2). The
remaining 22 lesions in 22 subjects were asymptomatic. For
the subsequent analysis, we combined the lesion types of mass
and architectural distortion into one lesion group.
Image Interpretation
The readers underwent dedicated training with five pilot
cases that were pathologically proven on a dedicated work-
station in our Breast Imaging Research Lab before starting
the reader study. For each case, the readers were allowed
to roam and zoom, adjust the contrast, and display the
images in coronal, sagittal, and axial planes. The readers
then individually reviewed a total of 34 randomized,
deidentified DBCT cases. The readers were blinded to the
clinical, mammographic, and pathologic results. The readers
were given a mandatory 15-minute break after each hour in
the reader study.
Each reader was asked for each case and for each lesion to
evaluate the breast density, the lesion type, the lesion loca-
tion, the lesion size in the longest dimension, the lesion
characteristics, and the BI-RADS assessment score using the
BI-RADS Mammography Atlas 5th Edition (6). All readers
were given paper data recording sheets to mark their answers.
Breast density was recorded as almost entirely fatty, scat-
tered areas of fibroglandular density, heterogeneously dense,
or extremely dense. Lesion type was classified as a mass, cal-
cifications, architectural distortion, or asymmetry. Table 2 lists
the BI-RADS terminology used in the present study. Figures 1
and 2 are an example of mass and calcification lesion cases,
respectively. Final assessment was assigned based on lesion char-
acterization according to the BI-RADS lexicon as previously
mentioned, and was classified into five categories (1 = neg-
ative, 2 = benign, 3 = probably benign, 4 = suspicious, and
5 = highly suggestive of malignancy).
Data Analysis and Statistics
All data for each reader in both reading conditions were
entered into a database and analyzed. We estimated the
sensitivity and specificity of DBCT according to mammo-
graphic lesion types from the four readers, where BI-RADS
categories 4 and 5 were diagnosed as malignancy. A gener-
alized estimating equation was used to produce such estimates,
and a compound symmetry working covariance was used.
Normal distributions were used to construct 95% confi-
dence intervals (CIs). The Fleiss k statistic was calculated to
assess interobserver agreement for reporting a primary finding,
TABLE 1. Cross-Tabulation of Lesion Type and Pathology
Type Mass Calcification AD Total
Pathology Benign, n (%) 19 (56) 5 (15) 2 (6) 26 (76)
Malignant, n (%) 5 (15) 2 (6) 1 (3) 8 (24)
Total, N (%) 24 (71) 7 (21) 3 (9) 34 (100)
AD, architectural distortion.









































lesion features, breast density, and final assessment among
the four readers. The guidelines of Landis and Koch were
followed in interpreting k values: a k value of equal to or
less than 0.20 means slight agreement; 0.21–0.40, fair agreement;
0.41–0.60, moderate agreement; 0.61–0.80, substantial agree-
ment; and 0.81–1.00, almost perfect agreement. The lesion
types of mass and architectural distortion were combined in
the statistical analysis.
Figure 1. Breast computed tomography images of a 44-year-old woman with a palpable mass in the upper central left breast diagnosed
with invasive ductal cancer, grade I. Dedicated breast computed tomography displays the three-dimensional image data set (coronal, sag-
ittal, and axial planes) and demonstrates a 1.5-cm irregular mass with a spiculated margin containing a calcification (circle).
Figure 2. Breast computed tomography images of a 48-year-old woman with asymptomatic calcifications in the medial left breast diag-
nosed as ductal carcinoma in situ. Dedicated breast computed tomography displays the three-dimensional image data set (coronal, sagittal,
and axial planes) and demonstrates a 1.2-cm, grouped, heterogeneous calcifications (circle).
Statistical analysis was performed using the SPSS version
20.0 software package (SPSS, Chicago, IL) and MedCalc version
14.10.2 (MedCalc Software, Mariakerke, Belgium).
RESULTS
Performances
The total reading time for all 34 cases was from 2 hours, 24
minutes, to 4 hours (mean of 3 hours, 27 minutes) in the four
readers. We examined the sensitivities and specificities of DBCT
according to mammographic lesion types from the four readers.
The results are shown in Table 3. The estimated overall sen-
sitivity was 0.969 (95% CI: 0.946–0.990), and the specificity
was 0.529 (95% CI: 0.456–0.601). For lesion types, the P values
comparing the sensitivity and specificity between the two types
of groups were 0.5896 and 0.2916, respectively. There were
no significant differences in the sensitivity and the specific-
ity between the lesion types.
Interobserver Variability
Nineteen of 24 mass-type lesions (79.2%) were detected as
mass by all of the four readers. The presence of all of the three
architectural distortions and three of seven calcification-type
lesions (42.9%) were noted by all four readers. For reporting
the presence of a primary finding, the overall agreement was
substantial (κ = 0.70). The agreement for the presence of 24
mass-type and 3 architectural distortion-type lesions (κ = 0.78)
was higher than that for the 7 calcification-type lesions
(κ = 0.52). Meanwhile, in assigning the final assessment, the
agreement was higher in calcification-type lesions (κ = 0.56)
than in mass- and architectural distortion-type lesions (κ = 0.22).
The results are shown in Table 3. In describing mass fea-
tures, the overall agreement for shape was fair (κ = 0.39); for
margin, moderate (κ = 0.455); and for density, slight (κ = 0.17).
Statistical analysis was not possible for agreement for assess-
ing calcification features because only three cases were visualized
by all four readers. The results are shown in Table 4.
DISCUSSION
We used the BI-RADS mammography atlas in reporting and
assigning the assessment for DBCT breast lesions, and its di-
agnostic performance and interobserver variability were
analyzed. We found that having radiologists use BI-RADS
for DBCT lesions resulted in overall high performance and
good agreement among readers.
According to Zhao et al. (31), in the receiver operating
characteristic curve analysis, the area under the curve of DBCT
was larger than that of two-view mammography (0.911 vs
0.827) for differentiating breast masses with BI-RADS. Our
results were similar to those of Zhao et al. study, and the overall
performance for assessing DBCT lesions with BI-RADS was
relatively high with a sensitivity of 0.969 and a specificity of
0.529.
For lesion types, there were no significant differences in es-
timated performances between mass- and architectural distortion-
type lesions and calcification-type lesions (sensitivity, 0.958 vs
1.000; specificity 0.572 vs 0.350; P = 0.5869 and P = 0.2916, re-
spectively). The performance of each radiologist can be affected
by work experience duration in breast imaging. In our study,
three of the four readers had 10 or more years of experience in
breast imaging, and one reader only had 1 year of experience.
However, we found that the number of years of the experi-
ence in breast imaging had no influence on the performance and
the agreement of reporting a primary finding and assigning the
BI-RADS final assessment and breast density. The reason might
be that all the readers had no experience of DBCT imaging as
part of their daily practice.
Lindfors et al. studied the clinical experience of DBCT and
reported that DBCT was equal to mammography for the vi-
sualization of breast masses, but mammography outperformed
TABLE 3. Sensitivities and Specificities of Readers for Different Lesion Types
Mass and AD Calcification Overall
Sensitivity Specificity Sensitivity Specificity Sensitivity Specificity
Reader 1 1.000 0.762 1.000 0.200 1.000 0.654
Reader 2 1.000 0.762 1.000 0.600 1.000 0.731
Reader 3 0.833 0.476 1.000 0.400 0.875 0.462
Reader 4 1.000 0.286 1.000 0.200 1.000 0.269
AD, architectural distortion.
TABLE 4. Interobserver Variability in Description of
Mammographic Lesions
BI-RADS Descriptor Kappa Value
Presence of primary finding
Overall 0.70






Mass and architectural distortion 0.22
Calcification 0.56
BI-RADS, Breast Imaging Reporting and Data System.
CT for the visualization of microcalcifications (23). In the most
recent study by Kuzmiak et al. (20), reader visualization con-
fidence of mass characterization using BI-RADS mammography
descriptors was significantly improved with DBCT com-
pared to digital mammography, but reduced for calcifications.
Currently, DBCT is regarded as inferior to mammography
in the visualization of calcifications because of its lower spatial
resolution, even though DCIS visualization on contrast-
enhanced DBCT was equal to mammography in a recent study
(32). The shape of a microcalcification group and the spatial
distribution of an individual microcalcification within it are
important indicators of malignancy; however, the resolution
of DBCT was too low to resolve the three-dimensional shape
of calcifications in our study. Among the seven calcification
cases in the present study, only three cases were visualized
by all of the four readers. In two of the calcification cases,
only two of the four readers visualized them. The remain-
ing two calcification cases were interpreted as mass or
architectural distortion by the readers. Therefore, our study
also suggested that the agreement for reporting the presence
of calcification-type lesions among the readers was lower than
that for mass- and architectural distortion-type lesions (κ = 0.52
vs κ = 0.78), but moderate agreement was obtained for
calcification-type lesions. Meanwhile, in assigning the final
assessment, the agreement was higher for calcification-type
lesions (κ = 0.56) than for mass- and architectural distortion-
type lesions (κ = 0.22). We noted that the overall agreement
on the final assessment was not high (κ = 0.30) in the present
study but was similar to the result (κ = 0.28) of a prior study
on interobserver variability for mammography using the BI-
RADS 4th Edition (33). Moreover, the agreement for mass
descriptors was also comparable to the prior results (33).
In this preliminary study, these results are encouraging in
lesion evaluation, especially in women with dense breasts where
the phenomenon of masking of lesions by normal breast tissue
is encountered.
Our study has several limitations. The first limitation is the
small cohort size, especially with regard to patients with ma-
lignant lesions. The small number of these cases may have
statistical bias. The second was that each lesion was marked
on the images for each study for the reader. This may result
in bias for the lesion perception of the readers. Third, we com-
bined the lesion type of mass and architectural distortion in
our data analysis. Consequently, this may result in data anal-
ysis error in the mass lesion type. Future studies with larger
numbers of lesions and different lesions types are needed.
In conclusion, the use of the BI-RADS Mammography
Atlas 5th Edition for DBCT showed high performance and
good agreement among readers. As with our current breast
imaging modalities, when new breast imaging tools emerge,
a standard terminology needs to be developed and updated
for radiologists to practice wisely and to provide outstand-
ing patient care. The BI-RADS Mammography Atlas 5th
Edition can be a potential starting point in breast lesion
characterization and assessment category with breast lesions
detected on DBCT.
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